Respiratory Disease Summaries Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Asthma

A

chronic inflammatory condition of the large and small airways that causes episodic exacerbations of bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma signs/symptoms

A
  • Diurnal variability. Typically, worse at night and early morning
  • Dry cough (Non-productive) with wheeze and shortness of breath
  • A history of other atopic conditions such as eczema, hayfever and food allergies
  • Associated atopy ↑IgE ( rhinitis , conjunctivitis, eczema)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Asthma management

A
  1. SABA
  2. Inhaled Corticosteroid e.g. beclometason
  3. LABA e.g. salmeterol
  4. Oral leukotriene antagonist, oral B2 agonist, oral theophylline or inhaled LAMA
  5. Titrate inhaled steroid
  6. Add in oral steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Omalizumab

A

inhibits the binding to the high-affinity IgE receptor which inhibits TH2 response and associated mediator release from basophils/mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABGs asthma

A

Initially patients will have a respiratory alkalosis as tachypnoea causes a drop in CO2.

A normal pCO2 or hypoxia is a concerning sign as it means they are tiring and indicates life threatening asthma.

A respiratory acidosis due to high CO2 is a very bad sign in asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Grading PEFR

A

Moderate: 50-75%
Severe: 33-50%
Life-threating: under 33%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute asthma management

A
  • O - oxygen - high flow 100%
  • S - salbutamol -Nebulised
  • H - hydrocortisone - given IV
  • I - ipratropium Bromide IV
  • T - theophylline
  • M - magnesium Sulphate
  • AN – anaesthetist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COPD

A

• Chronic obstructive pulmonary disease (COPD) is a non-reversible, long term deterioration in air flow through the lungs caused by damage to lung tissue.

Chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COPD investigations

A

Spirometry: >0.75% and no reversibility to salbutamol <15%

  • Full blood count for polycythaemia or anaemia. Polycythaemia (raised haemoglobin) is a response to chronic hypoxia.
  • Baseline BMI to assess weight loss (e.g. cancer or severe COPD) or weight gain (e.g. steroids).
  • Sputum culture to assess for chronic infections such as pseudomonas.
  • ECG and echocardiogram to assess heart function.
  • CT thorax for alternative diagnoses such as fibrosis, cancer or bronchiectasis.
  • Serum alpha-1 antitrypsin to look for alpha-1 antitrypsin deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COPD management

A
  1. beta-2 agonists
  2. No asthmatic or steroid responsive features: combined long-acting beta agonist (LABA) plus a long acting muscarinic antagonist

Or

Asthmatic or steroid responsive features: combined long acting beta agonist (LABA) plus an inhaled corticosteroid (ICS).

  1. LABA, LAMA and ICS e..g trimbo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Exacerbation of COPD

A

Acute worsening of symptoms such as cough, shortness of breath, sputum production and wheeze.

It is usually triggered by a viral or bacterial infection.
o Haemophilus influenzae & Moraxella catarrhalis, Streptococcus pneumoniae, Gram-negatives & others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COPD exacerbation Ix

A

Chest x-ray to look for pneumonia or other pathology

ECG to look for arrhythmia or evidence of heart strain (heart failure)

FBC to look for infection (raised white cells)

U&E to check electrolytes which can be affected by infection and medications

Sputum culture if significant infection is present

Blood cultures if septic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

management of COPD exacerbation

A

o Nebulised bronchodilators (e.g. salbutamol 5mg/4h and ipratropium 500mcg/6h)
o 24-28% Oxygen titrated against PaO2/PaCO2
o Antibiotics if evidence of infection e.g. amoxicillin or doxycycline
o Steroids (e.g. 200mg hydrocortisone or 30-40mg oral prednisolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

idiopathic pulmonary fibrosis causes

A

secondary: o rheumatoid, SLE, systemic sclerosis, asbestos, alpha-1-antitripsin deficiency
,drugs - amiodarone, bleomycin, penicillamine, nitrofurantoin, methotrexate, cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IPF Investigations

A
  • Restrictive defect on PFT’s - reduced FEV1 and FVC with normal or raised FEV1/FVC ratio, reduced lung volumes, low gas transfer
  • CxR - bilateral infiltrates;
  • CT scan - reticulonodular fibrotic shadowing, worse at the lung bases, and periphery.
  • High resolution CT scan of the thorax – ground glass appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IPF management

A

steroids and immunosuppressants to slow disease down

Pirfenidone: anti-fibrotic and anti-inflammatory
Nintedanib: tyrosine kinase monoclonal antibody

oxygen

lung transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis)

A

type III hypersensitivity reaction to an environmental allergen . Causes parenchymal inflammation and destruction

allergens: o Bird-fanciers lung is a reaction to bird droppings (avian proteins)
o Farmers lung is a reaction to mouldy spores in hay (thermophilic bacteria)
o Mushroom workers’ lung is a reaction to specific mushroom antigens (fungi)
o Malt workers lung is a reaction to mould on barley

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis) signs/symptoms

A

acute: several hours after acute exposure - cough episodic breathless, fever and myalgia, crackles (no wheeze)
chronic: progressive breathless and cough, may be crackles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis) investigations

A
  • CxR pulmonary fibrosis - most commonly in the upper zones due to better ventilation of the upper lobes then the lower
  • PFTs: restrictive defect (low FEV1 & FVC, high or normal ratio, low gas transfer - TLCO)
  • Lung biopsy if in doubt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

hypersensitivity pneumonitis management

A

o2, steroids and antigen avoidance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cryptogenic Organising Pneumonia

A

focal area of inflammation of the lung tissue. This can be idiopathic or triggered by infection, inflammatory disorders, medications, radiation or environmental toxins or allergens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cryptogenic Organising Pneumonia Mx

A

steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sarcoidosis

A

multisystem granulomatous inflammatory condition (type IV hypersensitivity). • Granulomas are nodules of inflammation full of macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

sarcoidosis classic triad

A
  • Erythema nodosum
  • Bilateral hilar lymphadenopathy
  • Polyarthralgia (joint pain in multiple joints)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

sarcoidosis diagnosis

A

Bloods:
o Raised serum ACE (screening)
o Hypercalcaemia
o Raised CRP
o Raised immunoglobulins
o U&Es, LFTS
o Urine dipstick or urine albumin-creatinine ratio to look for proteinuria indicating nephritis
o Ophthalmology
o ECG and echocardiogram for heart involvement
o Ultrasound abdomen for liver and kidney involvement

Imaging
o Chest x-ray shows hilar lymphadenopathy
o High resolution CT thorax shows hilar lymphadenopathy and pulmonary nodules
o MRI can show CNS involvement
o PET scan can show active inflammation in affected areas
• Biopsy: Non-caseating granulomas with epithelioid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

sarcoidosis management

A

acute: nothing or oral steroids
chronic: oral steroids, immunosuppression e.g. azathioprine, methotrexate, anti-TNF therapy, lung transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

asbestosis

A

lung fibrosis related to the inhalation of asbestos.

o Benign pleural plaques – asymptomatic: usually develop future complications
o Acute asbestos pleuritis - fever, pain, bloody pleural effusion
o Pleural Effusion and Diffuse pleural thickening - restrictive impairment

adenocarcinoma and malignant mesothelioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Coal workers pneumoconiosis

A

occupational disease (type of pneumoconiosis) caused by exposure to coal dust free of silica (washed coal).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

types of coal workers pneuumoconiosis

A

Simple pneumoconiosis
o chest X-ray abnormality only
o no impairment of lung function - often associated with chronic obstructive pulmonary disease

Complicated pneumoconiosis
o progressive massive fibrosis - restrictive pattern with breathlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Lung cancer types

A

• Non-small cell lung cancer:
o Squamous cell carcinoma (35%): pink keratin
o Adenocarcinoma (25%): glands mucin – most common with non-smokers
o large cell carcinoma (10%): undifferentiated

Small Cell Lung Cancer (SCLC) (20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

signs/symptoms of lung cancer

A
SOB
Cough >3 weeks 
Haemoptysis 
hoarse voice 
finger clubbing 
stridor 
anaemia 
unexplained weight loss 
recurrent pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

lung cancer investigations

A

FBC, Coagulation screen, Na, K, Ca, Alk Phos

FEV
CXR
CT Scan: lung to adrenal glands
PET-CT scans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

management non-small cell lung cancer

A

surgery: pneumonectomy, lobectomy and segmentectomy

radiotherapy

chemotherapy: adjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

small cell lung cancer management

A

chemotherapy and radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

mesothelioma

A

• Lung malignancy affecting the mesothelial cells of the pleura or very occasionally of the lining of the abdominal cavity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

mesothelioma investigations

A

Imaging: pleural nodularity, pleural thickening, local invasion and lung entrapment
• Aspiration: Low cytological yield and protein > 30 g/L (exudate)
• Investigate if cancer in pleural space is malignant or not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Mesothelioma management

A

• Pleurodesis: adhere your lung to your chest wall to prevent fluid or air from continually building up around your lungs
o TALC sclerosing agent: minor pleuritic pain and fever
o Long term pleural catheters: malignant effusion
o TS spend longer in hospital and need more rescue procedures
o IPC have more adverse event
• Radiotherapy
• Surgery
• Chemotherapy can improve survival but it is essentially palliative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Pleural effusion

A

abnormal collection of fluid in the pleural cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Classification of pleural effusion

A

Exudative: high protein count (>3g/dL)
o Related to inflammation: protein leaks out of the tissues into pleural space (moving out) e.g. Malignancy, pneumonia, RA, trauma and TB

Transudative: lower protein count (<3g/dL).
o Fluid moving across into pleural space e.g. Congestive cardiac failure, hypoalbuminaemia, hypothyroidism, Meig’ syndrome (right sided pleural effusion with ovarian malignancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Lights criteria

A

exudative if
1. fluid protein: serum protein >0.5

  1. fluid LDH: serum LDH >0.6
  2. Fluid LDH > 2/3rds normal upper limit of serum LDH
  3. Fluid cholesterol level is over 45 mg/dl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

pleural effusion Iv

A

CXR: blunting of costophrenic angle and meniscus in larger effusions

Aspiration or chest drain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Pleural effusion management

A

small effusions can resolve and treat underling cause e.g. heart failure

Larger: aspiration or drainage and chest drain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Empyema

A

infected pleural effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Empyema organisms

A

Aerobic organisms most frequently

Gram Positive: Strep Milleri and Staph Aureus

Gram Negatives: E-Coli, Pseudomonas, Haemophilus Influenzae and Kelbsiellae

45
Q

Complicated parapneumonic effusion

A

pH < 7.2, LDH > 1000, Glucose < 2.2: Using up glucose

empyema: frank pus

46
Q

empyema signs/symptoms

A

improving pneumonia but on going or new fever

pleuritic chest pain

swinging fever

47
Q

Empyema Iv

A
CXR: persisting effusion - D sign
USS
CT
CRP rise despite antibiotics 
albumin dropping: low 30s and 20s
48
Q

Empyema management

A

chest drain, IV amox and metroidazole and then oral antibiotics usually 5 weeks (co-amoxiclav)

49
Q

Primary vs secondary pneumothorax

A

Primary spontaneous (normal lungs) Pneumothorax may be asymptomatic even if moderately sized

Secondary Spontaneous (infection, asthma or copd): Pneumothorax usually symptomatic even if small

50
Q

Pneumothorax inv

A

Erect CXR:

  • small <2cm of air
  • large >2cm of air

CT thorax

51
Q

Primary Pneumothorax management

A

no SOB and <2cm - no treatment

if SOB and >2cm of air - aspiration and chest drain

52
Q

Secondary Pneumothorax management

A

• Unstable patients or bilateral or secondary pneumothoraces generally require a chest drain and admission for 24 hours
o In a small pneumothorax, <1cm, that is not causing severe shortness of breath the management is with admission, oxygen, and reassessment in 24 hours.
o If the pneumothorax was 1-2cm aspiration should be attempted
o >2cm, a chest drain should be inserted.

53
Q

Tension pneumothorax

A

trauma to chest wall that creates a one-way valve that lets air in but not out of the pleural space.

54
Q

PE prophylaxis

A

increased risk: LMWH e.g. enoxaparin

TED stockings

55
Q

PE signs/symptoms

A

• Shortness of breath
• Cough with or without blood (haemoptysis)
• Pleuritic chest pain
• Hypoxia
• Tachycardia
• Tachypnoea
• Cyanosis
• Crackles, rub, pleural effusion
• Low grade fever
• Haemodynamic instability causing hypotension
• Deep vein thrombosis such as unilateral hot, red, leg swelling and tenderness
o Proximal (iliofemoral – most likely) and distal (popliteal – least likely)

56
Q

Diagnosis of PE

A

USS: DVT
CXR: Normal early on before infarction, basal atelectasis, consolidation
ABG: respiratory alkalosis: high respiratory rate to blow CO2 off (low CO2 – blood becomes alkalotic). pO2 will be low
Wells score:
- likely CTPA
- unlikely d dimer, then CTPA

ECG: S1Q3T3 patterns
troponin and BNP: right heart strain
Echo

57
Q

PE management

A

Initial management: LMWH

Long term: warfarin, NOAC or LMWH

  • if warfarin (continue LMWH for 5 days)
  • DOACs (direct-acting oral anticoagulants) are essentially oral anticoagulants that are not warfarin e.g. apixaban, dabigatran and rivaroxaban
  • LMWH: pregnancy and cancer

Low risk: home
High risk: might require thrombolysis (alteplace), oxygen, analgesia

58
Q

Pulmonary hypertension

A

increased resistance and pressure of blood in the pulmonary arteries. Causes strain on right hand side of heart

Normal pressure is 12-20 mmhg. High >25

59
Q

Pulmonary hypertension Ix

A

ECG: RVH. large R waves in V1-3 and S eaves in V4-6

CXR: Dilated pulmonary arteries, RV hypertrophy & cardiomegaly

Raised NT-porBNF

measureed right heart catheter

60
Q

Primary pulmonary hypertension management

A
  1. exclude secondary causes
  2. prophylactic warfarin
  3. o2 if hypoxic
  4. pulmonary vasodilators
     Ca2+ channel blockers (oral nifedipine ,diltiazem)
     Endothelin antagonist (Oral Bosentan, Macitentan)
     PDE5-inhibitor (Oral Sildenafil/Tadalafil)
     Prostanoids (IV Epoprostenol or Inhaled Iloprost)
     Soluble Guanylate Cyclase stimulator (Riociguat)
  5. Lung transplant
61
Q

Obstructive Sleep Apnoea

A

Obstructive sleep apnoea is caused by intermittent collapse of the pharyngeal airway during sleep. characterised by apnoea episodes during sleep where the person will stop breathing periodically for up to a few minutes.

62
Q

OSA management

A
remove undelrying cause 
stop drinking, smoking and lose weight 
CPAP 
Mandivbualr devices
Surgery
63
Q

Acute bronchitis

A

short-term inflammation of the bronchi (large and medium-sized airways) of the lungs.

arises from Strep. pneumoniae/H. influenzae infections, or in people with COPD.

64
Q

acute bronchitis signs/symptoms

A
  • Productive cough
  • Wheeze
  • Breathlessness
  • Mild fever
  • Normal chest examination
  • Normal chest X-ray
  • May have a transient wheeze
65
Q

acute bronchitis management

A

self limiting

antibiotics only if chronic lung disease e.g. copd and amox

66
Q

Metapneumovirus

A

lower respiratory tract infection, particularly in young children and infants

67
Q

Bordetella pertussis

A

whooping cough (acute trachea-bronchitis)

68
Q

whooping cough signs/symptoms

A

mild coryzal symptoms (around 2 weeks), a low grade fever and possibly a mild dry cough. week or more: more severe coughing fits start after a week or more.

These involve sudden and recurring attacks of coughing with cough free periods in between. This is described as a paroxysmal cough.

69
Q

whooping cough Iv

A

nasopharyngeal or nasal swab with PCR testing or bacterial culture
more than 2 weeks patients can be tested for the anti-pertussis toxin immunoglobulin G

70
Q

Whooping cough management

A

Azithromycin, erythromycin and clarithromycin can be beneficial in the early stages (within the first 21 days) or vulnerable patients

71
Q

Pneumonia

A

Infection involving the distal airspaces usually with inflammatory exudation (“localised oedema”).

Fluid filled air spaces lead to consolidation (normally liquid) due to infection which impairs gas exchange

72
Q

Pneumonia bacteria causes

A

Streptococcus pneumoniae (50%)

Haemophilus influenzae (20%): elderly and underlying lung condition

Moraxella catarrhalis in immunocompromised patients or those with chronic pulmonary disease

Pseudomonas aeruginosa in patients with cystic fibrosis or bronchiectasis

Staphylococcus aureus in patients with cystic fibrosis and after influenza episode

atypical: legionella (hyponatraemia/SIADH/GI disturbance), mycoplasma pneumonia (erythema multiforme), chlmaydophilia pneuomiae, chlamydia trachomatis , chlamydia psittaci, coxiella burnetti

73
Q

CURB-65 Score

A

• C – Confusion (new disorientation in person, place or time)
• U – Urea > 7
• R – Respiratory rate ≥ 30
• B – Blood pressure < 90 systolic or ≤ 60 diastolic.
• 65 – Age ≥ 65
o Score 0/1: Consider treatment at home
o Score ≥ 2: Consider hospital admission
o Score ≥ 3: Consider intensive care assessment

74
Q

CAP antibiotics

A

0-2 Mild/Mod: Amoxicillin 1g tds IV/PO: Total 5 days. If penicillin allergic: Doxycycline PO 200mg on day 1 then 100mg od or IV Clarithromycin* if NBM (total 5days)

3-5 Severe: Co-amoxiclav IV 1.2g tds + Doxycycline PO 100mg bd: 7 days . If penicillin allergic: IV Levofloxacin 500mg bd monotherapy

ICU/HDU or NBM: Co-amoxiclav IV 1.2g tds + Clarithromycin* IV 500mg bd. If penicillin allergic: IV Levofloxacin 500mg bd monotherapy)

Step down: Doxycycline 100mg bd for ALL patients with severe CAP TOTAL IV/PO 7 days

75
Q

HAP antibiotics

A

Non severe: PO Amoxicillin (Total 5 days) If penicillin allergic: Doxycycline 100mg bd): TOTAL 5 days

Severe: IV Amoxicillin + Gentamicin. If penicillin allergic: IV Co-trimoxazole + Gentamicin)

Step down: PO Co-trimoxazole TOTAL IV/PO 7 days

76
Q

Aspiration pneumonia antibiotics

A

Non severe: PO Amoxicillin + Metronidazole. If penicillin allergic: PO Doxycycline 100mg bd + Metronidazole) TOTAL 5 days

Severe: IV Amoxicillin + Metronidazole + Gentamicin. If penicillin allergic: replace amoxicillin with PO Doxycycline or IV Clarithromycin*

Step down: PO Amoxicillin + Metronidazole
o If penicillin allergic: Doxycycline 100mg bd + Metronidazole TOTAL IV/PO 7 days

77
Q

Intrapulmonary lung abscess

A

Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities (more than 2 cm) containing necrotic debris or fluid caused by microbial infection.

78
Q

lung abscess signs/symptoms

A
  • Tumour-like
  • Chronic malaise (general feeling of discomfort) and swinging fever
  • Weight loss common
  • Lethargy, tiredness, weakness
  • Cough ± sputum (foul smelling)+/- haemoptysis
  • Pleuritic chest pain
  • Finger clubbing, crepitations and anaemia
79
Q

Lung abscess Iv

A
  • Blood: FBC, ESR, CRP, blood cultures
  • Sputum: microscopy, culture and cytology
  • CXR: walled cavity often with fluid level
  • CT: exclude obstruction
  • Bronchoscopy: diagnostic specimens
80
Q

Lung abscess management

A
  • Antibiotics: guided by culture results – continue until healed (4-6 weeks)
  • Postural drainage
  • Repeated aspiration
  • Surgical drainage may be required
81
Q

Septic emboli

A

embolism that is infected with bacteria, resulting in the formation of pus.

Can cause right sided endocarditis, infected DVT and septicaemia

82
Q

Septic emboli management

A
  • Treat underlying infection and cause
  • Antibiotics – culture
  • draining an abscess.
  • removing or replacing infected prostheses.
  • repairing a heart valve damaged by the infection
83
Q

Bronchiectasis

A

Abnormal localised irreversible (fixed) dilation and thinning of the bronchial tree (bronchi). Usually due to fibrous scarring following infection (pneumonia, tuberculosis, cystic fibrosis) and chronic obstruction (tumour) which pulls open the airways

84
Q

signs/symptoms of bronchiectasis

A
  • Persistent cough with persistent sputum production
  • Intermittent haemoptysis
  • Recurrent “chest infections”
  • Recurrent antibiotic prescriptions
  • No response to antibiotics
  • Short lived response to antibiotics
  • Finger clubbing, course inspiratory crepitations, wheeze
85
Q

bronchiectasis diagnosis

A
  • Clinical: Cough productive of sputum, chest pain and recurrent LRTIs
  • Sputum Culture: S. aureus, Pseudomonas, HiB
  • Other: IgA deficiency, CF (sweat test), aspergillus precipitins
  • CXR: dilated + thickened bronchi (cystic shadows)
  • HRCT: High-resolution computed tomography: Signiant ring – thicken airway and next to it is a pulmonary artery and however the bronchi is bigger than the artery
  • Spirometry: obstructive pattern with reversibility assessed
  • Bronchoscopy: assess site of haemoptysis, exclude obstruction and obtain samples for culture
86
Q

bronchiectasis management

A

physio, antibiotics, bronchodilators and anti-inflammatory agents
itraconazole

87
Q

low dose macrolides antibiotics: pseudomonas colonised individuals

A

bronchiectasis

88
Q

Antigenic drift

A

variation in viruses that involves the accumulation of mutations within the genes that code for antibody-binding sites

89
Q

influenza management

A

suspected flu and risk of complications:

  • oral oseltamivir 75mg
  • inhaled zanamivir 10mg

Post exposure prophylaxis

  • chronic disease or immunosuppression (within 48 hours)
  • oral oseltamivir 75mg for 10s
  • inhlaed zanamivir 10mg for 10 days
90
Q

TB systemic symptoms

A

lethargy, fever, night sweats, wt loss, cough (with haemoptysis), lymphadenopathy, erythema nodosum

91
Q

Tb Iv

A

Ziehl Neelsen stain

Mantoux test

Interferon gamma release assay

CXR

Cultures: sputum, mycobacterium blood cultures and lymph node biopsy

Nucleic Acid Amplification Test

92
Q

Latent TB management

A

Isoniazid and rifampicin for 3 months

Isoniazid for 6 months

93
Q

Acute pulmonary TB Mx

A

R – Rifampicin for 6 months (red/orange urine/tears and can affect COCP)

I – Isoniazid for 6 months – peripheral neuropathy – Vitamin B6 prophylactically

P – Pyrazinamide for 2 months (hyperuricaemia: gout)

E – Ethambutol for 2 months (colour blindness and reduce visual acuity)

Isolate for 2 weeks

94
Q

CF gene and variants

A

chromosome 7 (long arm)

delta F508 (5 classes)
G551D mutation (type II mutation)
95
Q

CF pathology

A

o Don’t get activation of the channel and the chloride stays in the cell (reduced chloride secretion) and sodium (loss of inhibition of sodium channels – excessive resorption) comes into the cell. Water follows the sodium causing the lumen to dry out and not be salty – dehydration of the lumen

96
Q

CF complications

A

Thick pancreatic and biliary secretions that cause blockage of the ducts, resulting in a lack of digestive enzymes such as pancreatic lipase in the digestive tract (Biliary obstruction, fibrotic pancreas and obstructive hepatitis)

Intestinal Blockage

Low volume thick airway secretions that reduce airway clearance, resulting in bacterial colonisation and susceptibility to airway infections

Congenital bilateral absence of the vas deferens in males.

Bronchiectasis

97
Q

signs/symptoms of CF

A
chronic cough
recurrent resp infections 
steatorrhoea (lack of pancreatic lipase)
abdominal pain 
poor wt and ht gain
crackles and wheeze on auscultation
98
Q

CF diagnosis

A

newborn blood spot
sweat test
genetic testing: amiocentesis or chorionic villous sampling

99
Q

Selective IgA deficiency

A

only class that can be transported across epithelium barriers in mucus secretions

100
Q

Common variable immunodeficiency (CVID)

A

is an immune disorder characterized by recurrent infections and low antibody levels, specifically in immunoglobulin (Ig) types IgG, IgM and IgA

101
Q

Severe congenital neutropenia (KOSTMANN SYNDROME)

A

Neutrophil development and mobilisation (AD)

102
Q

Kostmann syndrome Mx

A

Immunoglobulin replacement therapy (IVIg) – intravenous immunoglobin

Aggressive management of infection

  • Oral/intravenous antibiotics and anti-fungals
  • Surgical draining of abscesses

Definitive therapy

  • Haematopoietic stem cell transplantation
  • Specific treatments: CGD – Gamma interferon therapy

Gene therapy

Treatment with recombinant G-CSF: Reduces infections

103
Q

Leukocyte adhesion deficiency

A

Very rare autosomal recessive primary immunodeficiency

Results in failure of neutrophil adhesion and migration to endothelial adhesion molecules

104
Q

Chronic granulmatous disease

A

Deficiency of the intracellular killing mechanism of phagocytes: absent respiratory burst

105
Q

X-linked SCID

A

45% of all severe combined immunodeficiency

Results in inability to respond to cytokines
 failure of T cell and NK cell development
 production of immature B cells

106
Q

DiGeorge syndrome

A
  • Deletion of chromosome 22q11
  • Failure of production of CD4+ and CD8+ T cells
  • Abnormality in early development of 3rd/4th pharyngeal pouch.
  • Structural abnormalities incl. absence of a thymus – no T cell maturation.
107
Q

Type II hypersensitivity

A

Goodpasture’s disease:
autoimmune disease that affects the lungs and kidneys
o pulmonary alveolar haemorrhage
o kidney disease (glomerulonephritis)

Defined by the presence of autoreactive antibodies to the α3 chain of type IV collagen present in the basement membranes of alveoli and glomeruli

108
Q

Type III hypersensitivity

A
•	In the presence of excess antigen, antibody binds forming small immune complexes. These are trapped in small blood vessels, joints and glomeruli results in:
•	Activation of complement
	→ cell lysis
	→ opsonisation
•	Opsonisation
	→ Antibody-mediated phagocytosis
•	Infiltration and activation of neutrophils and macrophages
	→ tissue damage
109
Q

PEX

A

failure of peripheral tolerance mechanisms due to defective/absent regulatory T cells (Tregs)